Thomas Bannister

Biasing Mu Opioid Receptor Signaling in vivo

Optimization of a novel and effective antiviral agent targeting Zika NS4B

Identification of approved drugs for BDNF insufficiency

Development of novel antivirals for arthritogenic alphavirus

Pharmacological targeting of nascent modulators of opioid signaling

Preclinical Studies for the Therapeutic Development of a Novel Neuroprotectant for ALS

Therapeutic Disruption of HIV Transcription by HIV-1 Tat Protein-Degrading Molecules

Pharmacological targeting of nascent modulators of opioid signaling

An Innovative Approach to Identify Correctors of Metabolic Complications in HIV

Preclinical Studies for the Therapeutic Development of a Novel Neuroprotectant for ALS

Identification of small molecules for neurological complications of HIV and substance abuse comorbidity

Midwest AViDD Center - CORE C

Midwest AViDD Center - Project 5

Biasing Mu Opioid Receptor Signaling in vivo

Synthesis and Evaluation of Functionally Biased Opioid Analgesics

Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers

Identification of novel anthelmintics through a target-based screen of a parasite ion channel

Therapeutic Targeting of Casein Kinase-1-delta in Primary Metastatic Breast Cancer